nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP2E1—Fingolimod—multiple sclerosis	0.255	0.307	CbGbCtD
Sulfadiazine—CYP2E1—Mitoxantrone—multiple sclerosis	0.12	0.144	CbGbCtD
Sulfadiazine—CYP3A4—Fingolimod—multiple sclerosis	0.0773	0.0931	CbGbCtD
Sulfadiazine—CYP2E1—Dexamethasone—multiple sclerosis	0.0622	0.0749	CbGbCtD
Sulfadiazine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0498	0.06	CbGbCtD
Sulfadiazine—CYP2C8—Dexamethasone—multiple sclerosis	0.0465	0.0559	CbGbCtD
Sulfadiazine—CYP3A4—Triamcinolone—multiple sclerosis	0.0378	0.0454	CbGbCtD
Sulfadiazine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0363	0.0437	CbGbCtD
Sulfadiazine—CYP2C9—Dexamethasone—multiple sclerosis	0.0324	0.039	CbGbCtD
Sulfadiazine—CYP3A4—Betamethasone—multiple sclerosis	0.0324	0.039	CbGbCtD
Sulfadiazine—CYP3A4—Prednisolone—multiple sclerosis	0.032	0.0385	CbGbCtD
Sulfadiazine—CYP3A4—Prednisone—multiple sclerosis	0.0302	0.0363	CbGbCtD
Sulfadiazine—CYP3A4—Dexamethasone—multiple sclerosis	0.0188	0.0227	CbGbCtD
Sulfadiazine—Neuritis—Betamethasone—multiple sclerosis	0.00135	0.00807	CcSEcCtD
Sulfadiazine—Neuritis—Dexamethasone—multiple sclerosis	0.00135	0.00807	CcSEcCtD
Sulfadiazine—Sepsis—Mitoxantrone—multiple sclerosis	0.00127	0.00764	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Cladribine—multiple sclerosis	0.00124	0.00743	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00121	0.00728	CcSEcCtD
Sulfadiazine—Eruption—Methotrexate—multiple sclerosis	0.00119	0.00713	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Azathioprine—multiple sclerosis	0.00119	0.00712	CcSEcCtD
Sulfadiazine—Neuritis—Prednisone—multiple sclerosis	0.00117	0.00703	CcSEcCtD
Sulfadiazine—Pancreatitis—Azathioprine—multiple sclerosis	0.00112	0.0067	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Mitoxantrone—multiple sclerosis	0.0011	0.0066	CcSEcCtD
Sulfadiazine—Erythema multiforme—Cladribine—multiple sclerosis	0.00106	0.00636	CcSEcCtD
Sulfadiazine—Skin exfoliation—Triamcinolone—multiple sclerosis	0.00106	0.00634	CcSEcCtD
Sulfadiazine—Skin exfoliation—Methylprednisolone—multiple sclerosis	0.00106	0.00633	CcSEcCtD
Sulfadiazine—Burning sensation—Methotrexate—multiple sclerosis	0.00105	0.00631	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Azathioprine—multiple sclerosis	0.00101	0.00604	CcSEcCtD
Sulfadiazine—Chills—Cladribine—multiple sclerosis	0.00101	0.00604	CcSEcCtD
Sulfadiazine—Pruritus—Fingolimod—multiple sclerosis	0.000995	0.00596	CcSEcCtD
Sulfadiazine—Diarrhoea—Fingolimod—multiple sclerosis	0.000962	0.00577	CcSEcCtD
Sulfadiazine—Skin exfoliation—Betamethasone—multiple sclerosis	0.00096	0.00575	CcSEcCtD
Sulfadiazine—Skin exfoliation—Dexamethasone—multiple sclerosis	0.00096	0.00575	CcSEcCtD
Sulfadiazine—Agranulocytosis—Azathioprine—multiple sclerosis	0.000948	0.00569	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Prednisolone—multiple sclerosis	0.000904	0.00542	CcSEcCtD
Sulfadiazine—Vascular purpura—Triamcinolone—multiple sclerosis	0.000899	0.00539	CcSEcCtD
Sulfadiazine—Headache—Fingolimod—multiple sclerosis	0.000881	0.00528	CcSEcCtD
Sulfadiazine—Erythema multiforme—Azathioprine—multiple sclerosis	0.000862	0.00517	CcSEcCtD
Sulfadiazine—Skin exfoliation—Prednisone—multiple sclerosis	0.000836	0.00501	CcSEcCtD
Sulfadiazine—Purpura—Triamcinolone—multiple sclerosis	0.000834	0.005	CcSEcCtD
Sulfadiazine—Arthralgia—Cladribine—multiple sclerosis	0.000831	0.00499	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Triamcinolone—multiple sclerosis	0.000831	0.00498	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Methylprednisolone—multiple sclerosis	0.000829	0.00497	CcSEcCtD
Sulfadiazine—Chills—Azathioprine—multiple sclerosis	0.000818	0.00491	CcSEcCtD
Sulfadiazine—Skin discolouration—Methotrexate—multiple sclerosis	0.00081	0.00486	CcSEcCtD
Sulfadiazine—Stomatitis—Mitoxantrone—multiple sclerosis	0.000801	0.0048	CcSEcCtD
Sulfadiazine—Oliguria—Methotrexate—multiple sclerosis	0.000794	0.00476	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Cladribine—multiple sclerosis	0.00078	0.00468	CcSEcCtD
Sulfadiazine—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.000767	0.0046	CcSEcCtD
Sulfadiazine—Anorexia—Cladribine—multiple sclerosis	0.00076	0.00456	CcSEcCtD
Sulfadiazine—Sepsis—Prednisone—multiple sclerosis	0.00076	0.00455	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.000754	0.00452	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	0.000754	0.00452	CcSEcCtD
Sulfadiazine—Sulfamethazine—ALB—multiple sclerosis	0.000748	0.316	CrCbGaD
Sulfadiazine—Pancreatitis—Prednisolone—multiple sclerosis	0.000741	0.00444	CcSEcCtD
Sulfadiazine—Hepatitis—Mitoxantrone—multiple sclerosis	0.000737	0.00442	CcSEcCtD
Sulfadiazine—Sulfamerazine—ALB—multiple sclerosis	0.000732	0.309	CrCbGaD
Sulfadiazine—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.000726	0.00435	CcSEcCtD
Sulfadiazine—Insomnia—Cladribine—multiple sclerosis	0.000721	0.00432	CcSEcCtD
Sulfadiazine—Leukopenia—Azathioprine—multiple sclerosis	0.000711	0.00426	CcSEcCtD
Sulfadiazine—Vascular purpura—Prednisone—multiple sclerosis	0.00071	0.00426	CcSEcCtD
Sulfadiazine—Skin exfoliation—Methotrexate—multiple sclerosis	0.000698	0.00419	CcSEcCtD
Sulfadiazine—Decreased appetite—Cladribine—multiple sclerosis	0.000693	0.00415	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000688	0.00413	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Methotrexate—multiple sclerosis	0.000687	0.00412	CcSEcCtD
Sulfadiazine—Pancreatitis—Triamcinolone—multiple sclerosis	0.000681	0.00409	CcSEcCtD
Sulfadiazine—Pancreatitis—Methylprednisolone—multiple sclerosis	0.00068	0.00408	CcSEcCtD
Sulfadiazine—Arthralgia—Azathioprine—multiple sclerosis	0.000676	0.00405	CcSEcCtD
Sulfadiazine—Chills—Mitoxantrone—multiple sclerosis	0.000662	0.00397	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Prednisolone—multiple sclerosis	0.000661	0.00396	CcSEcCtD
Sulfadiazine—Purpura—Prednisone—multiple sclerosis	0.000659	0.00395	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000652	0.00391	CcSEcCtD
Sulfadiazine—Sepsis—Methotrexate—multiple sclerosis	0.000635	0.00381	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000635	0.0038	CcSEcCtD
Sulfadiazine—Urticaria—Cladribine—multiple sclerosis	0.000633	0.0038	CcSEcCtD
Sulfadiazine—Body temperature increased—Cladribine—multiple sclerosis	0.00063	0.00378	CcSEcCtD
Sulfadiazine—Abdominal pain—Cladribine—multiple sclerosis	0.00063	0.00378	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Triamcinolone—multiple sclerosis	0.000607	0.00364	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Methylprednisolone—multiple sclerosis	0.000606	0.00363	CcSEcCtD
Sulfadiazine—Polyuria—Methotrexate—multiple sclerosis	0.000605	0.00363	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.00059	0.00354	CcSEcCtD
Sulfadiazine—Hypersensitivity—Cladribine—multiple sclerosis	0.000587	0.00352	CcSEcCtD
Sulfadiazine—Leukopenia—Mitoxantrone—multiple sclerosis	0.000575	0.00345	CcSEcCtD
Sulfadiazine—Sulfamethizole—ALB—multiple sclerosis	0.000567	0.24	CrCbGaD
Sulfadiazine—Pruritus—Cladribine—multiple sclerosis	0.000564	0.00338	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Methotrexate—multiple sclerosis	0.000563	0.00337	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000559	0.00335	CcSEcCtD
Sulfadiazine—Convulsion—Mitoxantrone—multiple sclerosis	0.000556	0.00333	CcSEcCtD
Sulfadiazine—Hallucination—Methylprednisolone—multiple sclerosis	0.000552	0.00331	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.000551	0.00331	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.000551	0.00331	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.000549	0.00329	CcSEcCtD
Sulfadiazine—Arthralgia—Mitoxantrone—multiple sclerosis	0.000546	0.00328	CcSEcCtD
Sulfadiazine—Diarrhoea—Cladribine—multiple sclerosis	0.000545	0.00327	CcSEcCtD
Sulfadiazine—Pancreatitis—Prednisone—multiple sclerosis	0.000538	0.00323	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00053	0.00318	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000524	0.00314	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000513	0.00308	CcSEcCtD
Sulfadiazine—Abdominal pain—Azathioprine—multiple sclerosis	0.000512	0.00307	CcSEcCtD
Sulfadiazine—Body temperature increased—Azathioprine—multiple sclerosis	0.000512	0.00307	CcSEcCtD
Sulfadiazine—Vomiting—Cladribine—multiple sclerosis	0.000507	0.00304	CcSEcCtD
Sulfadiazine—Rash—Cladribine—multiple sclerosis	0.000503	0.00301	CcSEcCtD
Sulfadiazine—Hallucination—Betamethasone—multiple sclerosis	0.000502	0.00301	CcSEcCtD
Sulfadiazine—Hallucination—Dexamethasone—multiple sclerosis	0.000502	0.00301	CcSEcCtD
Sulfadiazine—Dermatitis—Cladribine—multiple sclerosis	0.000502	0.00301	CcSEcCtD
Sulfadiazine—Anorexia—Mitoxantrone—multiple sclerosis	0.000499	0.00299	CcSEcCtD
Sulfadiazine—Ataxia—Methotrexate—multiple sclerosis	0.000499	0.00299	CcSEcCtD
Sulfadiazine—Headache—Cladribine—multiple sclerosis	0.000499	0.00299	CcSEcCtD
Sulfadiazine—Depression—Prednisone—multiple sclerosis	0.000488	0.00293	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Prednisone—multiple sclerosis	0.00048	0.00288	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000478	0.00287	CcSEcCtD
Sulfadiazine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000477	0.00286	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000477	0.00286	CcSEcCtD
Sulfadiazine—Nausea—Cladribine—multiple sclerosis	0.000473	0.00284	CcSEcCtD
Sulfadiazine—Vertigo—Prednisolone—multiple sclerosis	0.000473	0.00284	CcSEcCtD
Sulfadiazine—Convulsion—Prednisolone—multiple sclerosis	0.000456	0.00274	CcSEcCtD
Sulfadiazine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000455	0.00273	CcSEcCtD
Sulfadiazine—Pancreatitis—Methotrexate—multiple sclerosis	0.00045	0.0027	CcSEcCtD
Sulfadiazine—Diarrhoea—Azathioprine—multiple sclerosis	0.000443	0.00266	CcSEcCtD
Sulfadiazine—Hallucination—Prednisone—multiple sclerosis	0.000437	0.00262	CcSEcCtD
Sulfadiazine—Vertigo—Triamcinolone—multiple sclerosis	0.000435	0.00261	CcSEcCtD
Sulfadiazine—Vertigo—Methylprednisolone—multiple sclerosis	0.000434	0.0026	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00043	0.00258	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000428	0.00257	CcSEcCtD
Sulfadiazine—Convulsion—Triamcinolone—multiple sclerosis	0.00042	0.00252	CcSEcCtD
Sulfadiazine—Convulsion—Methylprednisolone—multiple sclerosis	0.000419	0.00251	CcSEcCtD
Sulfadiazine—Urticaria—Mitoxantrone—multiple sclerosis	0.000416	0.0025	CcSEcCtD
Sulfadiazine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000414	0.00248	CcSEcCtD
Sulfadiazine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000414	0.00248	CcSEcCtD
Sulfadiazine—Vomiting—Azathioprine—multiple sclerosis	0.000412	0.00247	CcSEcCtD
Sulfadiazine—Arthralgia—Methylprednisolone—multiple sclerosis	0.000411	0.00247	CcSEcCtD
Sulfadiazine—Rash—Azathioprine—multiple sclerosis	0.000409	0.00245	CcSEcCtD
Sulfadiazine—Dermatitis—Azathioprine—multiple sclerosis	0.000408	0.00245	CcSEcCtD
Sulfadiazine—Depression—Methotrexate—multiple sclerosis	0.000408	0.00245	CcSEcCtD
Sulfadiazine—Headache—Azathioprine—multiple sclerosis	0.000406	0.00243	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000406	0.00243	CcSEcCtD
Sulfadiazine—Stomatitis—Methotrexate—multiple sclerosis	0.000399	0.00239	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000395	0.00237	CcSEcCtD
Sulfadiazine—Vertigo—Dexamethasone—multiple sclerosis	0.000395	0.00237	CcSEcCtD
Sulfadiazine—Vertigo—Betamethasone—multiple sclerosis	0.000395	0.00237	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000394	0.00236	CcSEcCtD
Sulfadiazine—Insomnia—Prednisolone—multiple sclerosis	0.000389	0.00233	CcSEcCtD
Sulfadiazine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000386	0.00231	CcSEcCtD
Sulfadiazine—Nausea—Azathioprine—multiple sclerosis	0.000385	0.00231	CcSEcCtD
Sulfadiazine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000382	0.00229	CcSEcCtD
Sulfadiazine—Convulsion—Dexamethasone—multiple sclerosis	0.000381	0.00228	CcSEcCtD
Sulfadiazine—Convulsion—Betamethasone—multiple sclerosis	0.000381	0.00228	CcSEcCtD
Sulfadiazine—Hepatitis—Methotrexate—multiple sclerosis	0.000367	0.0022	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00036	0.00216	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000359	0.00215	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000359	0.00215	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000359	0.00215	CcSEcCtD
Sulfadiazine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000358	0.00215	CcSEcCtD
Sulfadiazine—Insomnia—Triamcinolone—multiple sclerosis	0.000357	0.00214	CcSEcCtD
Sulfadiazine—Insomnia—Methylprednisolone—multiple sclerosis	0.000357	0.00214	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000351	0.00211	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000351	0.00211	CcSEcCtD
Sulfadiazine—Erythema multiforme—Methotrexate—multiple sclerosis	0.000347	0.00208	CcSEcCtD
Sulfadiazine—Vertigo—Prednisone—multiple sclerosis	0.000344	0.00206	CcSEcCtD
Sulfadiazine—Tinnitus—Methotrexate—multiple sclerosis	0.000343	0.00205	CcSEcCtD
Sulfadiazine—Anorexia—Dexamethasone—multiple sclerosis	0.000342	0.00205	CcSEcCtD
Sulfadiazine—Anorexia—Betamethasone—multiple sclerosis	0.000342	0.00205	CcSEcCtD
Sulfadiazine—Urticaria—Prednisolone—multiple sclerosis	0.000341	0.00205	CcSEcCtD
Sulfadiazine—Vomiting—Mitoxantrone—multiple sclerosis	0.000333	0.002	CcSEcCtD
Sulfadiazine—Convulsion—Prednisone—multiple sclerosis	0.000332	0.00199	CcSEcCtD
Sulfadiazine—Rash—Mitoxantrone—multiple sclerosis	0.00033	0.00198	CcSEcCtD
Sulfadiazine—Dermatitis—Mitoxantrone—multiple sclerosis	0.00033	0.00198	CcSEcCtD
Sulfadiazine—Chills—Methotrexate—multiple sclerosis	0.00033	0.00198	CcSEcCtD
Sulfadiazine—Headache—Mitoxantrone—multiple sclerosis	0.000328	0.00197	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000327	0.00196	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000327	0.00196	CcSEcCtD
Sulfadiazine—Arthralgia—Prednisone—multiple sclerosis	0.000326	0.00195	CcSEcCtD
Sulfadiazine—Insomnia—Dexamethasone—multiple sclerosis	0.000324	0.00194	CcSEcCtD
Sulfadiazine—Insomnia—Betamethasone—multiple sclerosis	0.000324	0.00194	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000322	0.00193	CcSEcCtD
Sulfadiazine—Sulfamethoxazole—ALB—multiple sclerosis	0.000318	0.135	CrCbGaD
Sulfadiazine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000317	0.0019	CcSEcCtD
Sulfadiazine—Urticaria—Triamcinolone—multiple sclerosis	0.000314	0.00188	CcSEcCtD
Sulfadiazine—Urticaria—Methylprednisolone—multiple sclerosis	0.000313	0.00188	CcSEcCtD
Sulfadiazine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000312	0.00187	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000312	0.00187	CcSEcCtD
Sulfadiazine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000312	0.00187	CcSEcCtD
Sulfadiazine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000312	0.00187	CcSEcCtD
Sulfadiazine—Decreased appetite—Betamethasone—multiple sclerosis	0.000312	0.00187	CcSEcCtD
Sulfadiazine—Nausea—Mitoxantrone—multiple sclerosis	0.000311	0.00187	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00031	0.00186	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00031	0.00186	CcSEcCtD
Sulfadiazine—Anorexia—Prednisone—multiple sclerosis	0.000298	0.00179	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000293	0.00176	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000293	0.00176	CcSEcCtD
Sulfadiazine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000291	0.00175	CcSEcCtD
Sulfadiazine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000291	0.00174	CcSEcCtD
Sulfadiazine—Vertigo—Methotrexate—multiple sclerosis	0.000287	0.00172	CcSEcCtD
Sulfadiazine—Leukopenia—Methotrexate—multiple sclerosis	0.000286	0.00172	CcSEcCtD
Sulfadiazine—Urticaria—Dexamethasone—multiple sclerosis	0.000285	0.00171	CcSEcCtD
Sulfadiazine—Urticaria—Betamethasone—multiple sclerosis	0.000285	0.00171	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000285	0.00171	CcSEcCtD
Sulfadiazine—Abdominal pain—Betamethasone—multiple sclerosis	0.000284	0.0017	CcSEcCtD
Sulfadiazine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000284	0.0017	CcSEcCtD
Sulfadiazine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000284	0.0017	CcSEcCtD
Sulfadiazine—Body temperature increased—Betamethasone—multiple sclerosis	0.000284	0.0017	CcSEcCtD
Sulfadiazine—Insomnia—Prednisone—multiple sclerosis	0.000282	0.00169	CcSEcCtD
Sulfadiazine—Pruritus—Triamcinolone—multiple sclerosis	0.00028	0.00168	CcSEcCtD
Sulfadiazine—Pruritus—Methylprednisolone—multiple sclerosis	0.000279	0.00167	CcSEcCtD
Sulfadiazine—Convulsion—Methotrexate—multiple sclerosis	0.000277	0.00166	CcSEcCtD
Sulfadiazine—Arthralgia—Methotrexate—multiple sclerosis	0.000272	0.00163	CcSEcCtD
Sulfadiazine—Decreased appetite—Prednisone—multiple sclerosis	0.000271	0.00163	CcSEcCtD
Sulfadiazine—Rash—Prednisolone—multiple sclerosis	0.000271	0.00162	CcSEcCtD
Sulfadiazine—Dermatitis—Prednisolone—multiple sclerosis	0.000271	0.00162	CcSEcCtD
Sulfadiazine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00027	0.00162	CcSEcCtD
Sulfadiazine—Headache—Prednisolone—multiple sclerosis	0.000269	0.00161	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000261	0.00157	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000256	0.00153	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000255	0.00153	CcSEcCtD
Sulfadiazine—Nausea—Prednisolone—multiple sclerosis	0.000255	0.00153	CcSEcCtD
Sulfadiazine—Pruritus—Betamethasone—multiple sclerosis	0.000254	0.00152	CcSEcCtD
Sulfadiazine—Pruritus—Dexamethasone—multiple sclerosis	0.000254	0.00152	CcSEcCtD
Sulfadiazine—Vomiting—Triamcinolone—multiple sclerosis	0.000251	0.00151	CcSEcCtD
Sulfadiazine—Vomiting—Methylprednisolone—multiple sclerosis	0.000251	0.0015	CcSEcCtD
Sulfadiazine—Rash—Triamcinolone—multiple sclerosis	0.000249	0.00149	CcSEcCtD
Sulfadiazine—Dermatitis—Triamcinolone—multiple sclerosis	0.000249	0.00149	CcSEcCtD
Sulfadiazine—Anorexia—Methotrexate—multiple sclerosis	0.000249	0.00149	CcSEcCtD
Sulfadiazine—Rash—Methylprednisolone—multiple sclerosis	0.000249	0.00149	CcSEcCtD
Sulfadiazine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000248	0.00149	CcSEcCtD
Sulfadiazine—Urticaria—Prednisone—multiple sclerosis	0.000248	0.00149	CcSEcCtD
Sulfadiazine—Headache—Triamcinolone—multiple sclerosis	0.000248	0.00148	CcSEcCtD
Sulfadiazine—Headache—Methylprednisolone—multiple sclerosis	0.000247	0.00148	CcSEcCtD
Sulfadiazine—Abdominal pain—Prednisone—multiple sclerosis	0.000247	0.00148	CcSEcCtD
Sulfadiazine—Body temperature increased—Prednisone—multiple sclerosis	0.000247	0.00148	CcSEcCtD
Sulfadiazine—Diarrhoea—Betamethasone—multiple sclerosis	0.000245	0.00147	CcSEcCtD
Sulfadiazine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000245	0.00147	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000238	0.00143	CcSEcCtD
Sulfadiazine—Insomnia—Methotrexate—multiple sclerosis	0.000236	0.00142	CcSEcCtD
Sulfadiazine—Nausea—Triamcinolone—multiple sclerosis	0.000235	0.00141	CcSEcCtD
Sulfadiazine—Nausea—Methylprednisolone—multiple sclerosis	0.000234	0.0014	CcSEcCtD
Sulfadiazine—Hypersensitivity—Prednisone—multiple sclerosis	0.00023	0.00138	CcSEcCtD
Sulfadiazine—Vomiting—Dexamethasone—multiple sclerosis	0.000228	0.00137	CcSEcCtD
Sulfadiazine—Vomiting—Betamethasone—multiple sclerosis	0.000228	0.00137	CcSEcCtD
Sulfadiazine—Decreased appetite—Methotrexate—multiple sclerosis	0.000227	0.00136	CcSEcCtD
Sulfadiazine—Rash—Betamethasone—multiple sclerosis	0.000226	0.00136	CcSEcCtD
Sulfadiazine—Rash—Dexamethasone—multiple sclerosis	0.000226	0.00136	CcSEcCtD
Sulfadiazine—Dermatitis—Betamethasone—multiple sclerosis	0.000226	0.00135	CcSEcCtD
Sulfadiazine—Dermatitis—Dexamethasone—multiple sclerosis	0.000226	0.00135	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000225	0.00135	CcSEcCtD
Sulfadiazine—Headache—Dexamethasone—multiple sclerosis	0.000225	0.00135	CcSEcCtD
Sulfadiazine—Headache—Betamethasone—multiple sclerosis	0.000225	0.00135	CcSEcCtD
Sulfadiazine—Pruritus—Prednisone—multiple sclerosis	0.000221	0.00132	CcSEcCtD
Sulfadiazine—Diarrhoea—Prednisone—multiple sclerosis	0.000214	0.00128	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000213	0.00128	CcSEcCtD
Sulfadiazine—Nausea—Betamethasone—multiple sclerosis	0.000213	0.00128	CcSEcCtD
Sulfadiazine—Nausea—Dexamethasone—multiple sclerosis	0.000213	0.00128	CcSEcCtD
Sulfadiazine—Urticaria—Methotrexate—multiple sclerosis	0.000207	0.00124	CcSEcCtD
Sulfadiazine—Body temperature increased—Methotrexate—multiple sclerosis	0.000206	0.00124	CcSEcCtD
Sulfadiazine—Abdominal pain—Methotrexate—multiple sclerosis	0.000206	0.00124	CcSEcCtD
Sulfadiazine—Vomiting—Prednisone—multiple sclerosis	0.000199	0.00119	CcSEcCtD
Sulfadiazine—Rash—Prednisone—multiple sclerosis	0.000197	0.00118	CcSEcCtD
Sulfadiazine—Dermatitis—Prednisone—multiple sclerosis	0.000197	0.00118	CcSEcCtD
Sulfadiazine—Headache—Prednisone—multiple sclerosis	0.000196	0.00117	CcSEcCtD
Sulfadiazine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000192	0.00115	CcSEcCtD
Sulfadiazine—Nausea—Prednisone—multiple sclerosis	0.000186	0.00111	CcSEcCtD
Sulfadiazine—Pruritus—Methotrexate—multiple sclerosis	0.000185	0.00111	CcSEcCtD
Sulfadiazine—Diarrhoea—Methotrexate—multiple sclerosis	0.000179	0.00107	CcSEcCtD
Sulfadiazine—Vomiting—Methotrexate—multiple sclerosis	0.000166	0.000995	CcSEcCtD
Sulfadiazine—Rash—Methotrexate—multiple sclerosis	0.000165	0.000987	CcSEcCtD
Sulfadiazine—Dermatitis—Methotrexate—multiple sclerosis	0.000164	0.000986	CcSEcCtD
Sulfadiazine—Headache—Methotrexate—multiple sclerosis	0.000164	0.00098	CcSEcCtD
Sulfadiazine—Nausea—Methotrexate—multiple sclerosis	0.000155	0.00093	CcSEcCtD
